{"transactions":[{"id":670934,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":17878,"kind":"person","name":"Abu-Absi Susan","position":1,"cik":"0002148701","reported_name":"Abu-Absi Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-01T21:21:45.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":265487,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest as follows: 25% of the options vest on August 10, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":265487,"derivative":{"exercise_price":7.43,"expiration_date":"2036-09-01","underlying":"Common Stock","underlying_shares":265487},"source":{"system":"sec-edgar","filing":"0002148701-26-000008","document":"form4-09012026_090941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000214870126000008/form4-09012026_090941.xml","form_type":"4"}},{"id":670933,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":17878,"kind":"person","name":"Abu-Absi Susan","position":1,"cik":"0002148701","reported_name":"Abu-Absi Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-01T21:21:45.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":134513,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities represent an inducement award granted pursuant to a restricted stock unit (\"RSU\") award agreement with the Issuer. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments, subject to the Reporting Person's continued service as of the relevant vesting date, with the first tranche scheduled to vest on September 15, 2027."}],"balance_after":134513,"source":{"system":"sec-edgar","filing":"0002148701-26-000008","document":"form4-09012026_090941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000214870126000008/form4-09012026_090941.xml","form_type":"4"}}]}